A Randomized Controlled Trial to Assess the Efficacy of Tiotropium in Canadian Patients with Chronic Obstructive Pulmonary Disease

Charles KN Chan; François Maltais; Chris Sigouin; Jennifer M Haddon; Gordon T Ford; on behalf of the SAFE Study Group

doi:10.1155/2007/192961

Canadian Respiratory Journal (Jan 2007)

A Randomized Controlled Trial to Assess the Efficacy of Tiotropium in Canadian Patients with Chronic Obstructive Pulmonary Disease

Charles KN Chan,
François Maltais,
Chris Sigouin,
Jennifer M Haddon,
Gordon T Ford,
on behalf of the SAFE Study Group

Affiliations

Charles KN Chan: University Health Network – Toronto General Hospital, Toronto, Ontario, Canada
François Maltais: Centre de recherche de l’Hôpital Laval, Institut universitaire de cardiologie et de pneumologie de l’Université Laval, Laval, Québec, Canada
Chris Sigouin: University of Toronto, Department of Health Policy, Management and Evaluation, Toronto, Canada
Jennifer M Haddon: Boehringer Ingelheim Canada Limited, Burlington, Ontario, Canada
Gordon T Ford: Respiratory Division, University of Calgary, Calgary, Alberta, Canada
on behalf of the SAFE Study Group

DOI: https://doi.org/10.1155/2007/192961
Journal volume & issue: Vol. 14, no. 8
pp. 465 – 472

Abstract

Read online

BACKGROUND: Patients with chronic obstructive pulmonary disease (COPD) who smoke have a greater annual rate of decline in forced expiratory volume in 1 s (FEV1) than those patients who have stopped smoking.

Published in Canadian Respiratory Journal

ISSN: 1198-2241 (Print); 1916-7245 (Online)
Publisher: Wiley
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Diseases of the respiratory system
Website: https://onlinelibrary.wiley.com/journal/7503

About the journal